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Abstract
Prevalence of pneumococcal serotypes in carriage and disease has been described but
absolute serotype colonisation densities have not been reported. 515 paediatric nasal
swab DNA extracts were subjected to lytA qPCR and molecular serotyping by microarray.
Absolute serotype densities were derived from total pneumococcal density (qPCR cycle
threshold and standard curve) and relative abundance (microarray) and varied widely.
Compared to all serotype densities observed, the strongest evidence of differences was
seen for serotypes 21 and 35B (higher) and 3, 38 and non-typeables (lower) (p<0.05) with a
similar hierarchy when only a single serotype carriage was assessed. There was no evi-
dence of any overall density differences between children with single or multiple serotypes
detected but serotypes with mid-range densities were more prevalent. The hierarchy of dis-
tinct pneumococcal serotype carriage densities described here for the first time, may help
explain the dynamics of transmission between children.
Introduction
Much attention has been devoted to differences in prevalence in carriage of pneumococcus
(Sp) and carriage of specific serotypes and how these correlate with prevalence in disease [1].
In the pre-pneumococcal conjugate vaccine (PCV) era, the rank order of serotypes found in
colonisation was reasonably stable across different populations with certain disease-causing
serotypes like serotypes 1 and 5 rarely detected [1,2]. Subsequent studies have suggested that
the diversity and overall relative prevalences of pneumococcal serotypes revert to a particular
population structure following the perturbation caused by universal childhoodPCV imple-
mentation [3,4]. Weinberger et al. [5] showed an association between increased carriage preva-
lence and resistance to non-opsonic neutrophil-mediated killing: the more prevalent serotypes,
such as 19F and 23F beingmost resistant, while types rarely isolated, such as 4 and 5, were
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more efficiently killed. Resistant serotypes tended to be more heavily encapsulated. An associa-
tion between polysaccharide structure and carriage prevalence was also identifiedwith more
common serotypes having less energy expended on capsule generation [5]. Other microbial
factors, such as adhesins, toxins and proteins that avoid host immune effectors, may also influ-
ence carriage prevalence of specific strains [6].
The tendency of certain serotypes to be undetectable in the nasopharynxmay also be associ-
ated with their low density and/or duration of carriage.Wide ranges of bacterial DNA concen-
trations in nasopharyngeal samples from healthy pre-school children carrying pneumococcus
have been shown using quantitative (q)PCR [7]. That simultaneous carriage of multiple Sp
serotypes occurs has long been known [8], but recent technical advances, notably microarray
detection, has made it feasible both to detect them and evaluate their relative abundance in a
sample [9]. Wyllie and colleagues published evidence suggesting that children colonised with
more Sp serotypes have higher overall carriage density than those with fewer [10]. Taken
together, these findings suggest that the well known serotype hierarchy of prevalence in car-
riage at the population level may overlie another hierarchy within individual children, with cer-
tain serotypes tending to be more abundant (and thus easily detected) than others.
Material and Methods
In March 2011 we took nasopharyngeal swabs from 515 healthy pre-school children in daycare
in Coimbra, Portugal. The study was approved by the Ethics Committee of Centro Hospitalar
de Coimbra and parents provided written informed consent for their child to participate. The
median age was 40 months (range 5–84 months) and 54% were male. Swabs were placed in
2mL cryovials containing 1.5mL soya tryptone glucose glycerine (STGG) transport and storage
medium. Although the samples are taken into STGG, raising the theoretical possibility of pro-
liferation after sampling, in practice these samples were placed into a cold box at 4°C immedi-
ately after collection and then frozen at -80°C within a few hours, so that very little if any
bacterial division is likely to have occurred.After storage at -80°C, DNA extracts were prepared
from 340μL medium and from colistin blood agar lawn cultures of 50μL medium and subjected
respectively to lytA qPCR as previously described [7]. Molecular serotyping was performed by
microarray (Senti-SP v1.4, BUGS Bioscience, London, UK; http://bugsbio.org) in order to
detect and quantify DNA from each serotype present [11]. Culturing STGG prior to DNA
extraction and microarray increases yields of pneumococcalDNA and thus sensitivity of detec-
tion of serotypes present at low abundance [12]. The microarray determines serotype(s) pres-
ent in the sample based on the combination of capsule polysaccharide biosynthesis (cps) genes
detected and assigns relative abundance using the signal intensity of cps genes associated with
each serotype [13]. Additionally, detection of non-encapsulated non-typeable (NT) pneumo-
coccal lineages lacking cps genes and discrimination of closely related streptococcus species,
such S.mitis, S. oralis and S. pseudopneumoniae that may contain cps gene homologues, is
possible.
A standard curve created using a log-phase reference strain broth culture was used to con-
vert lytA qPCR cycle threshold (Ct) values into total Sp density in gene copies/mL as previously
reported [7]. Absolute densities were calculated as follows: for those samples where a single
serotype is present, the absolute density is simply the total density of Sp measured by PCR;
where more than one serotype were isolated, the total density was adjusted according to the rel-
ative abundance of each serotype as obtained by microarray. The distribution of absolute den-
sity for all serotypes was fitted to a log-normal distribution using maximum likelihood
estimation implemented in the R package ‘fitdistrplus’ (S1 Fig). Each individual serotype distri-
bution was log-transformed and compared to the log-transform of all serotypes using a two-
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sidedWelch’s t-test. The results were confirmedwith a Kolmogorov-Smirnov non-parametric
test on the absolute values (not log-transformed). All analyses were performed in R version
3.2.3 (2015-12-10), using the following packages: ggplot2 (2.0.0), fitdistrplus (1.0–6) [14].
Results
Sp was detected by lytA qPCR in 337/515 swabs (65.4%), 299 of which showed Sp and/or
closely related species bearing cps gene homologues detected by microarray.
The absolute density of Sp, X, has a range over 5 orders of magnitude, between 0.45–
107148, and is well describedby a log-normal distribution,X*lnN(μ,σ2), with μ = 6.10 (95%
CI 5.98–6.22) and σ = 2.43 (95% CI 2.35–2.52), giving a median of absolute density of 447.9
gene copies/mL (95% CI 395.5–507.2). 31 distinct serotypes plus non-typeables (NT) were
identified among 400 isolates. The number of children (out of 299) carrying only one Sp sero-
type (or NT) was 210, carrying two was 77, 3 was 8 and 4 was 4. The absolute density, grouped
by serotype, for the 210 single serotype carriers is shown in the Fig 1A, with the median density
of the whole ensemble plotted as a guide to the eye (vertical dotted line). To test the hypothesis
that the apparent differences between serotype densities were unlikely to have occurred by
chance, we compared each serotype with all the observations including NTs combined
together. The strongest evidence of differences was seen for serotypes 21 and and non-type-
ables (lower) (p<0.05 t-test and KS test). All serotypes, including instances of multiple serotype
carriage are shown in the same order in Fig 1B. In this larger dataset there is also strong evi-
dence of differences for 35B (higher) and 3 and 38 (lower) (p<0.05 t-test and KS test). For sev-
eral others, although there were too few instances to power a comparison at p<0.05, the
apparent differences were often large, with 10A, 35F and 23A showing higher density with
p<0.1.
To confirm the results of the statistical tests, we also performed the following permutation-
based test. The vector of serotype labels was shuffled and the mean serotype density for each
(shuffled) serotype was computed. This procedure was repeated 10,000 times and the actual
(real sample) mean for was compared to the distribution of 10,000 shuffledmean values, com-
puting its quintile. We found that the mean density of serotypes 21 and 35B fell above the 95th
percentile of the shuffledmean distribution, and the mean density for serotype 3 and 38 fell
below the 5th percentile of the shuffledmean distribution. This further supports the results of
the KS test and t-tests.
In contrast to the only previous study to examine this [10], no evidencewas found for any
relationship between total absolute density of Sp and the number of serotypes detected in each
sample (Fig 2).
To clarify the relationship between serotype density and colonisation potential, serotype fre-
quency (the relative abundance of a particular serotype in the population) is shown as a func-
tion of median serotype density, for all samples (Fig 3).
Those serotypes showing an intermediate density range (median between 400–8,000 gene
copies/mL) include those that are most abundant in the population unlike serotypes that
appear at low densities, or more surprisingly, serotypes colonising at high density. Thus our
data suggest that intermediate density may be a necessary condition for high prevalence in the
population, but not a sufficient one.
Discussion
The observation that certain disease causing serotypes are very rarely detected in carriage has
led to speculation that they are usually present with others and only at low densities. Our data
suggest, for the first time, that a hierarchy of serotype carriage densities may exist. Although
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the culture enrichment step usedmay have amplified different strains present together to a dif-
ferent extent, microarray results from culture-amplifiedmixtures of serotypes have been
shown to correlate well with unculturedmixtures [9] and differences were also evident
Fig 1. Serotype against observed absolute densities of pneumococcal serotypes. Serotype against observed absolute density for samples
where a single serotype or strain was identified in the microarray (A) and for all samples (B). The red dots denote individual measurements of density.
In the box and whisker plots, for each serotype, the central line denotes the median of the distribution, the box edges denote upper and lower quartiles
and the whiskers extend 1.5 times the interquartile range past the quartiles. The black dots denote outliers (also shown in red), and the dotted vertical
line marks the overall median as a guide to the eye. Numbers of measurements for each serotype are shown to the right of the y axis. Boxplots are
ordered by median value, from lowest (bottom) to highest (top) of the solo serotypes in both panels.
doi:10.1371/journal.pone.0163435.g001
Fig 2. Distribution of carriage density for serotype. Kernel Density plot showing the distribution of density plotted for different
numbers of distinct serotypes recovered per child. The density of carriage does not differ with the number of serotypes found.
doi:10.1371/journal.pone.0163435.g002
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amongst samples with only a single serotype detected. Given the sampling error and technical
limitations that must inevitably commonly lead to failure to detect organisms that are present
in low abundance and not swabbed or which fall below detection limits, these results suggest
that pneumococci and closely genetically related bacteria usually colonise young children and
are perhaps transmitted between them as a complex mixed community rather than as a single
strain.
The prevalences of all pneumococcal serotypes in carriage decline uniformly with increasing
age in pre-school children [15] and subsequent modelling proposes an erosion of serotype-spe-
cific selective advantage by putative serotype-non-specificanti-protein immune responses
[16]. Our results show a slight downward trend in overall pneumococcal density with increas-
ing age, which is not statistically significant (data not shown). However, it remains theoretically
possible that the apparent differences in carriage density of different serotypes we show here
could be due, at least in part, to differential age-related effects on different serotypes.
Fig 3. Serotype density against relative abundance. Serotype density against observed relative abundance. For each serotype, the
median density is plotted against the relative abundance as a percentage of the entire sample, and horizontal lines denote interquartile
ranges. Coloured symbols denote individual serotypes.
doi:10.1371/journal.pone.0163435.g003
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If a quantitative hierarchy of density between serotypes normally exists, it is possible that
imbalances induced, for example, by acquisition of new strains or species of bacteria, immune
responses to vaccines and other changes in host immunity, intercurrent viral infections, antibi-
otic use or exposure to environmental smoke, could predispose to mucosal symptomatic or
invasive infection. In addition, it is likely that a complex interplay of bacterial and host factors
affects the population structure [16].
Accordingly, studies of colonisation in disease and in the presence of these other risk factors,
examining serotypes and strain density are warranted.
These observations also call into question the validity of continuing to focus on colonising
bacteria as individual species, defined by highly selected and somewhat arbitrary phenotypic
features relevant to in vitro culture more than in vivo biology. Such categorisation ignores the
natural tendency of bacteria to co-exist and evolve across these boundaries. This is exemplified
by the detection of numerous closely related Streptococcus species in this dataset, which bear
homologues of the Sp cps genes [17]. One can debate whether or not to include them in analy-
ses when they are evidently present and play a part in the biology of colonisation, probably
donating DNA to as well as receiving it from the gene pool available in the nasopharyngeal
niche.
Further detailed studies of colonisation in young children are clearly needed if the mecha-
nisms of transmission, interruption of which seems to be critical for current vaccination strate-
gies, and of development of disease, the predictors of which remain obscure, are to be
understood.
Supporting Information
S1 Fig. Distribution of serotype density and log-normal fit. The empirical probability den-
sity function (pdf)of serotype density (bars), compared to the fitted log-normal distribution
(red line), plotted on a semi-logarithmic scale, showing a reasonable fit.
(TIF)
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